Correction to: Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma

被引：0
|
作者：
Ofer Margalit
Shun Yu
Einat Shacham-Shmueli
Gal Strauss
Yu-Xiao Yang
Yaacov R. Lawrence
Kim A. Reiss
Talia Golan
Naama Halpern
Dan Aderka
Bruce Giantonio
Ronac Mamtani
Ben Boursi
机构：
[1] Sheba Medical Center,Institute of Oncology
[2] Tel-Aviv University,Center for Clinical Epidemiology and Biostatistics
[3] Perelman School of Medicine at the University of Pennsylvania,Abramson Cancer Center
[4] University of Pennsylvania,Division of Gastroenterology, Department of Medicine
[5] Perelman School of Medicine at the University of Pennsylvania,Department of Radiation Oncology
[6] Sidney Kimmel Medical College at Thomas Jefferson University,Division of Hematology and Oncology, Department of Medicine
[7] Massachusetts General Hospital,undefined
[8] Harvard Medical School,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2022年 / 148卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1709 / 1709
相关论文
共 50 条
  • [31] Antibiotic administration and outcome of patients with advanced gastric cancer receiving programmed death-1 inhibitors or with single-agent chemotherapy
    Jung, M.
    Kim, C. G.
    Shin, S-J.
    Hong, M.
    Chung, H. C.
    Rha, S. Y.
    Kim, H. S.
    Lee, C-K.
    Lee, J. H.
    Han, Y.
    Kim, H.
    Kim, J. H.
    Lee, S. Y.
    Jeung, H-C.
    ANNALS OF ONCOLOGY, 2021, 32 : S1061 - S1061
  • [32] Single-agent paclitaxel at first relapse following adjuvant chemotherapy for breast cancer
    Davidson, NG
    SEMINARS IN ONCOLOGY, 1995, 22 (06) : 2 - 6
  • [33] The symptomatic benefit (the clinical benefit response) from the second-line chemotherapy in patients with advanced gastric adenocarcinoma
    Sencan, O.
    Buyukcelik, A.
    Yalcin, B.
    Boruban, M. C.
    Akbulut, H.
    Demirkazik, A.
    Senler, F. C.
    Onur, H.
    Icli, F.
    EUROPEAN JOURNAL OF CANCER CARE, 2008, 17 (01) : 26 - 32
  • [34] Association of Adjuvant Chemotherapy With Overall Survival Among Patients With Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
    Lin, Jian-Xian
    Tang, Yi-Hui
    Lin, Guan-Jie
    Ma, Yu-Bin
    Desiderio, Jacopo
    Li, Ping
    Xie, Jian-Wei
    Wang, Jia-Bin
    Lu, Jun
    Chen, Qi-Yue
    Cao, Long-Long
    Lin, Mi
    Tu, Ru-Hong
    Zheng, Chao-Hui
    Parisi, Amilcare
    Truty, Mark J.
    Huang, Chang-Ming
    JAMA NETWORK OPEN, 2022, 5 (04)
  • [35] Combination or single-agent chemotherapy as adjuvant treatment for pancreatic cancer? Opening opinion: combination chemotherapy
    Conroy, Thierry
    Van Laethem, Jean-Luc
    LANCET ONCOLOGY, 2019, 20 (03): : 336 - 337
  • [36] Adjuvant chemotherapy in the elderly population with locally advanced rectal cancer: A single-centre retrospective review
    Liu, Shiru Lucy
    Lamond, Nathan William Dana
    Orr, Christine
    Bricks, Corey Sean
    Hopman, Wilma M.
    Hammad, Nazik
    Ramjeesingh, Ravi
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [37] Survival benefit and impact of adjuvant chemotherapy following neoadjuvant therapy in patients with locally advanced rectal cancer
    Zheng, Pengwen
    Xu, Mengzhen
    Ma, Dening
    Feng, Longhai
    Qin, Jing
    Gao, Xinyi
    UPDATES IN SURGERY, 2025,
  • [38] Oral topotecan as single-agent second-line chemotherapy in patients with advanced ovarian cancer
    Clarke-Pearson, DL
    Van Le, L
    Iveson, T
    Whitney, CW
    Hanjani, P
    Kristensen, G
    Malfetano, JH
    Beckman, RA
    Ross, GA
    Lane, SR
    DeWitte, MH
    Fields, SZ
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (19) : 3967 - 3975
  • [39] Neoadjuvant chemoradiation versus adjuvant chemotherapy for locally advanced adenocarcinoma of the rectosigmoid junction
    Salami, A. C.
    Obaid, T.
    Nweze, N. J.
    Deleon, M.
    Force, L.
    Gorgun, E.
    Wexner, S.
    Joshi, A. R. T.
    COLORECTAL DISEASE, 2020, 22 (05) : 513 - 520
  • [40] Benefit of adjuvant chemoradiotherapy in patients with pathologically lymph node-positive and locally advanced gastric cancer
    Shanhui Zhang
    Fei Zhou
    Donghai Liang
    Hongying Lv
    Hongsheng Yu
    Oncology and Translational Medicine, 2020, 6 (02) : 72 - 80
12345